MDT
$93.95-0.89%
as of close, Oct 27, 2026
☾ AH $93.95 -0.89%
MDT — Medtronic plc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
80.090.0100.0110.0120.0130.00200.0M$93.95—20162019202120242026
2026-10-27
Price$93.95
MA20$86.56
MA50$90.99
Vol28.8M
Key stats#
Price data
- Price
- $93.95
- YTD price return
- -2.20%
- YTD total return
- +0.31%
- Next earnings
- Nov 17, 2026
- Market cap
- 120.2B
- Enterprise value
- 141.4B
- Shares outstanding
- 1.3B
- 52W low
- $73.31
- 52W high
- $106.33
- From 52W high
- -11.64%
- From 52W low
- +28.15%
- 52W range
- 63%
- Beta
- 0.55
Volume
- Rel volume
- 0.21×
- 30D volume
- 26.4M
- 30D $ vol
- 2.4B
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$5.8M
- Insider net 3M
- −$5.9M
- Insider net 1Y
- −$11.6M
Form 4 transactions by trade date, as filed; latest on file 2026-10-15.
Fundamentals
- Sales (ttm)
- 37.5B
- Sales/share
- $29.35
- EPS (ttm)
- $4.06
- FCF (ttm)
- 6.1B
- FCF/share
- $4.79
- Book value/share
- $39.27
- Net margin
- 13.93%
- ROE
- 10.41%
- ROA
- 5.61%
- Debt / equity
- 0.51×
- Current ratio
- 2.07
Growth (CAGR, ttm) · 10Y
- Sales
- +9.61%+5.94%+3.51%+2.71%
- Net income
- +12.05%+13.02%+6.14%+3.67%
- FCF
- +15.37%+11.29%+0.93%+2.48%
- Shares
- -0.27%-1.30%-1.01%-0.77%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +12.00%+14.32%+7.24%+4.68%
- Sales/share
- +9.91%+7.33%+4.56%+3.51%
- FCF/share
- +15.69%+12.76%+1.96%+3.27%
- Book value/share
- +5.09%+0.69%+0.52%+0.66%
- Dividend/share
- +1.40%+1.44%+3.76%+6.14%
- Price
- -0.19%+10.60%-5.17%+1.48%
- Total return
- +3.12%+14.29%-2.09%+4.25%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 23.1×
- P/OI (ttm)
- 17.7×
- Fwd P/E
- 14.9×
- P/S (ttm)
- 3.2×
- P/B (mrq)
- 2.4×
- P/FCF (ttm)
- 19.6×
- EV/EBITDA (fy)
- 14.5×
- EV/Sales (ttm)
- 3.8×
- FCF yield (ttm)
- 5.10%
- Dividend yield (fwd)
- 3.07%
- Dividend yield (ttm)
- 3.04%
- Dividend/share (fwd)
- $2.88
- Buyback yield (realized, 1y)
- 0.27%
- Shareholder yield (realized, 1y)
- 3.33%
- Buyback yield (cash, ttm)
- 0.61%
- Shareholder yield (cash, ttm)
- 3.65%
Vs own 10Y history
- P/E
- 10th
- P/OI
- 12th
- P/S
- 10th
- P/B
- 56th
- P/FCF
- 8th
Bar = where today’s multiple sits in MDT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-0.89%
5D
-0.72%
1M
+5.99%
3M
+11.55%
YTD
-2.20%
1Y
-0.19%
5Y
-23.31%
Recent filings#
- Oct 198-K · Medtronic Completes Separation of MiniMed Group, Inc.
- Sep 16Insider sale · KIIL HARRY SKIP (EVP & President Cardiovascular) sold 1,483 shares for $139K at $93.65
- Sep 1Earnings · Earnings release — EPS $1.45 vs $1.39 est. (+4.3%); revenue $9.76B (+14% y/y) 1.5%
Financial statements
Open full MDT financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
